Metabolism
Metabolism(代谢)
- PPAR(219)
- 5-alpha Reductase(11)
- 5-Lipoxygenase(11)
- Adenosine Deaminase(10)
- Aminopeptidase(15)
- C14ɑ demethylase(2)
- Carbonic Anhydrase(55)
- CETP(9)
- Cholesterol absorption(1)
- CPT1(2)
- CYP3A/CYP450(22)
- Dehydrogenase(43)
- DHFR(7)
- DGAT(10)
- Dopamine β-hydroxylase(10)
- Enolase(5)
- FAAH(38)
- Factor Xa(61)
- Ferroptosis(198)
- Folate Analogue(2)
- Glucokinase(18)
- HLE(1)
- HMG-CoA Reductase(37)
- HSP(100)
- IDO(46)
- KRAS-PDEδ(3)
- MAO(6)
- Metabolic Enzymes(6)
- Neuronal Metabolism(8)
- Oxidative Phosphorylation(26)
- P450(456)
- PDE(250)
- Phospholipase(130)
- Procollagen C Proteinase(1)
- Saccharometabolism(1)
- SCD(20)
- SGLT(29)
- TPH(4)
- Transferase(26)
- Energy Metabolism
- Inorganic Ions
- ALP(1)
- Carbohydrates(36)
- Uric Acid
- Muscle Metabolism
- MDA
- MPO
- Transaminase(3)
- Glutathione Reductase(1)
- Thioredoxin Reductase
- Catalase(15)
- monooxygenase(1)
- PKM2(1)
- Aldehyde dehydrogenase(1)
- Squalene synthase(1)
- Hydrolase(17)
- ornithine decarboxylase(1)
- Amino acid metabolism(3)
- phosphatases(103)
- Pyruvate kinase(13)
- Others(64)
- MGL(1)
- Galactosidase(2)
- 12-Lipoxygenase(1)
- Fatty Acid Synthase (FASN)(9)
- Dihydroorotate Dehydrogenase(13)
- Bile Acids & Microbiome(131)
- Bone Growth & Remodeling(55)
- Carbohydrate Metabolism(166)
- Cofactors & Vitamins(87)
- Dyslipidemias(109)
- Inborn Errors of Metabolism(100)
- Metabolic Syndrome(22)
- Necroptosis(12)
- Necrosis(19)
- Nutrient Sensing(14)
- Phosphodiesterase(34)
- Reproductive Biology(184)
- Thermogenesis(10)
- Sterol Biosynthesis(42)
- Prolyl Hydroxylation Enzymes(2)
- Biliary System(16)
- Metabolic Disease(5)
- Fat Mass and Obesity-associated Protein (FTO)(5)
- SHIP(1)
- FOXO
- Furin(1)
- Liposome(8)
- MetAP
- PGC-1α
- PI5P4K(1)
- Metabolic Diseases(2)
Metabolism 相关产品(3072)
- GC15272TroglitazoneCAS: 97322-87-7纯度: >98.50% / >98.00% / >96.00%
Troglitazone是一种具有口服活性的过氧化物酶体增殖物激活受体γ(PPARγ)激动剂,对人和鼠的EC 50 值分别为550nM和780nM。
- GC15274PF-04620110CAS: 1109276-89-2纯度: >99.00% / >98.00%
PF-04620110是一种口服有效的选择性二酰甘油酰基转移酶-1(DGAT1)抑制剂(IC 50 = 19nM)。
- GC15295AUY922 (NVP-AUY922)CAS: 747412-49-3纯度: >99.50% / >98.00%
AUY922 (NVP-AUY922)是一种高效且选择性的 HSP90抑制剂,对 HSP90α和 HSP90β的 IC 50 值分别为 13nM和 21nM。
- GC15475RS 25344 hydrochlorideCAS: 152815-28-6纯度: >99.50%
RS 25344 hydrochloride 是一种选择性 cAMP-磷酸二酯酶 4 (PDE 4; PDE IV) 抑制剂,对人淋巴细胞的 IC50 为 0.28 nM。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC15189 | Gisadenafil besylate | 334827-98-4 | - | |
A PDE5 inhibitor | ||||
| GC15194 | PF-2545920 | 1292799-56-4 | - | |
A potent inhibitor of PDE10A | ||||
| GC15272 | Troglitazone | 97322-87-7 | >98.50% / >98.00% / >96.00% | |
Troglitazone是一种具有口服活性的过氧化物酶体增殖物激活受体γ(PPARγ)激动剂,对人和鼠的EC 50 值分别为550nM和780nM。 | ||||
| GC15274 | PF-04620110 | 1109276-89-2 | >99.00% / >98.00% | |
PF-04620110是一种口服有效的选择性二酰甘油酰基转移酶-1(DGAT1)抑制剂(IC 50 = 19nM)。 | ||||
| GC15295 | AUY922 (NVP-AUY922) | 747412-49-3 | >99.50% / >98.00% | |
AUY922 (NVP-AUY922)是一种高效且选择性的 HSP90抑制剂,对 HSP90α和 HSP90β的 IC 50 值分别为 13nM和 21nM。 | ||||
| GC15318 | GW501516 | 317318-70-0 | >99.00% | |
GW501516是一种合成PPARδ特异性激动剂,EC 50 值为0.10nM。 | ||||
| GC15358 | PF 750 | 959151-50-9 | >98.00% | |
A selective, potent FAAH inhibitor | ||||
| GC15382 | Isotretinoin | 4759-48-2 | >99.50% | |
A retinoid | ||||
| GC15472 | BRL 50481 | 433695-36-4 | >99.50% | |
A potent, selective inhibitor of PDE7 | ||||
| GC15475 | RS 25344 hydrochloride | 152815-28-6 | >99.50% | |
RS 25344 hydrochloride 是一种选择性 cAMP-磷酸二酯酶 4 (PDE 4; PDE IV) 抑制剂,对人淋巴细胞的 IC50 为 0.28 nM。 | ||||
| GC15516 | Rosiglitazone HCl | 302543-62-0 | - | |
A PPARγ agonist | ||||
| GC15541 | Fluvastatin Sodium | 93957-55-2 | >99.50% / >98.00% | |
An HMG-CoA reductase inhibitor | ||||
| GC15544 | AP-III-a4 | 1177827-73-4 | >98.00% | |
A small molecule enolase inhibitor | ||||
| GC15558 | Mildronate | 76144-81-5 | >98.00% | |
An inhibitor of carnitine biosynthesis | ||||
| GC15605 | Ezetimibe | 163222-33-1 | >99.50% / >99.00% | |
Ezetimibe是一种选择性胆固醇吸收抑制剂,对肺癌细胞(A549)和人胚肾细胞(HEK293)的IC 50 为50µM,对黑色素瘤细胞(A375)的IC 50 为30µM,作用时间均为48h。 | ||||
| GC15614 | A922500 | 959122-11-3 | >98.50% | |
A922500是一种有效、选择性高且具有口服活性的二酰基甘油酰基转移酶1(DGAT-1)抑制剂,对人源和小鼠DGAT-1的IC 50 值分别为9和22nM。 | ||||
| GC15757 | Ozagrel | 82571-53-7 | >99.50% | |
A selective inhibitor of TXA synthase | ||||
| GC15848 | Torcetrapib | 262352-17-0 | >99.00% | |
A CETP inhibitor | ||||
| GC15890 | Cilostazol | 73963-72-1 | >99.50% | |
A PDE3A inhibitor | ||||
| GC15951 | URB597 | 546141-08-6 | >99.00% | |
An inhibitor of FAAH | ||||
| GC16009 | GSK3787 | 188591-46-0 | >99.00% | |
A selective, irreversible PPARβ/δ antagonist | ||||
| GC16012 | PF-04971729 | 1210344-57-2 | >98.00% | |
An SGLT2 inhibitor | ||||
| GC16014 | Zileuton | 111406-87-2 | >99.00% | |
Zileuton是一种苯并噻吩N-羟基脲类化合物,作为口服5-脂氧合酶抑制剂。 | ||||
| GC16048 | BC 11-38 | 686770-80-9 | >98.00% | |
A potent and selective PDE11 inhibitor | ||||
